Insulin glargine and lixisenatide and Onabotulinumtoxina Intramuscular
Determining the interaction of Insulin glargine and lixisenatide and Onabotulinumtoxina Intramuscular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: onabotulinumtoxinA
Brand name: Botox, Botox Cosmetic
Synonyms: OnabotulinumtoxinA
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Onasemnogene Abeparvovcec Infusion
- Insulin glargine and lixisenatide-Onasemnogene Abeparvovec
- Insulin glargine and lixisenatide-Onasemnogene abeparvovec Zolgensma
- Insulin glargine and lixisenatide-Oncaspar
- Insulin glargine and lixisenatide-Oncovin
- Insulin glargine and lixisenatide-Ondansetron
- Onabotulinumtoxina Intramuscular-Insulin glargine and lixisenatide Subcutaneous
- Onabotulinumtoxina Intramuscular-Insulin glargine, recombinant Subcutaneous
- Onabotulinumtoxina Intramuscular-Insulin glulisine
- Onabotulinumtoxina Intramuscular-Insulin Glulisine (Cartridges and Pens)
- Onabotulinumtoxina Intramuscular-Insulin Glulisine (Vials)
- Onabotulinumtoxina Intramuscular-Insulin glulisine Subcutaneous